Target intelligence / Profile preview

Denatured collagen triple-helix structural motif (dCol)

Target
dCol
Molecular classification
Extracellular matrix protein, Structural protein motif, Other
01

Overview

The denatured collagen triple-helix structural motif refers to the unfolded or degraded state of collagen proteins, which are the primary structural components of the extracellular matrix (ECM) (NIH.gov; 3helix.com). In healthy tissues, collagen exists as a stable, triple-helical structure that is highly resistant to most proteolytic enzymes (YouTube.com; NIH.gov). However, during pathological conditions such as cancer, inflammation, and mechanical injury, the triple helix is cleaved by matrix metalloproteinases (MMPs) or physically disrupted, causing the strands to spontaneously unfold at physiological temperatures (3helix.com; NIH.gov). This denaturation exposes cryptic binding sites and individual alpha chains that are not accessible in intact collagen, making the motif a highly specific biomarker for active tissue damage and remodeling (Ilexlife.com; NIH.gov). Therapeutic and diagnostic strategies, most notably Collagen Hybridizing Peptides (CHPs), target this motif by re-hybridizing with the exposed strands to form a new, stable triple helix (NIH.gov; Wikipedia.org). This unique mechanism enables the targeted delivery of imaging agents and drugs to diseased environments, such as the invasive front of tumors or the degraded cartilage in arthritic joints (NIH.gov). Experimental applications include the localization of anti-TNF alpha antibodies to arthritic joints and the imaging of tumor-associated ECM remodeling (NIH.gov). Because the collagen sequence is highly conserved, these targeting agents can be applied across various species and collagen types (3helix.com).

Other names
Unfolded collagenDamaged collagenDegraded collagenCryptic collagen epitopesGelatinRemodeling collagen
02

Mechanism of action

Triple-helical hybridization with denatured collagen strands to deliver therapeutic or imaging payloads

03

Biological functions

Extracellular matrix remodelingTissue repairCell signalingOther
04

Disease associations

CancerInflammationFibrosisCardiovascular diseaseOther
05

Safety considerations

Off-target binding in physiological remodeling sitesShort half-life of peptide-based probesPotential immunogenicity of synthetic peptides
06

Interacting drugs

Collagen hybridizing peptide (CHP)

2 more in the full profile.

07

Biomarkers

Denatured collagenMMP-degraded collagenUnfolded collagen alpha chains

Beyond the preview

Go deeper on Denatured collagen triple-helix structural motif (dCol).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Denatured collagen triple-helix structural motif (dCol).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call